Multilevel Regulation of N-methyladenosine RNA Modifications: Implications in Tumorigenesis and Therapeutic Opportunities

Overview

Journal Genes Dis

Date 2023 Jul 26

PMID 37492716

Authors

Lili Feng

Rongrong Du

Baitong Chang

Min Li

Jie Tian

Shengjun Wang

Affiliations

Soon will be listed here.

Abstract

N-methyladenosine (mA) RNA modification is widely perceived as the most abundant and common modification in transcripts. This modification is dynamically regulated by specific mA "writers", "erasers" and "readers" and is reportedly involved in the occurrence and development of many diseases. Since mA RNA modification was discovered in the 1970s, with the progress of relevant research technologies, an increasing number of functions of mA have been reported, and a preliminary understanding of mA has been obtained. In this review, we summarize the mechanisms through which mA RNA modification is regulated from the perspectives of expression, posttranslational modification and protein interaction. In addition, we also summarize how external and internal environmental factors affect mA RNA modification and its functions in tumors. The mechanisms through which mA methylases, mA demethylases and mA-binding proteins are regulated are complicated and have not been fully elucidated. Therefore, we hope to promote further research in this field by summarizing these mechanisms and look forward to the future application of mA in tumors.

Citing Articles

Analysis of m6A-regulated genes and subtype classification in lupus nephritis.

Li D, Li Y, Zhu K, Yuan Y, He Z, Sun Q BMC Nephrol. 2024; 25(1):119.

PMID: 38570749 PMC: 10988804. DOI: 10.1186/s12882-024-03549-3.

METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma.

Zhang Z, Fu J, Zhang Y, Qin X, Wang Y, Xing C BMC Gastroenterol. 2023; 23(1):217.

PMID: 37344779 PMC: 10283274. DOI: 10.1186/s12876-023-02844-x.

References

Ma C, Ding J, Ye T, Yuan B, Feng Y . AlkB Homologue 1 Demethylates -Methylcytidine in mRNA of Mammals. ACS Chem Biol. 2019; 14(7):1418-1425. DOI: 10.1021/acschembio.8b01001. View

Knuckles P, Lence T, Haussmann I, Jacob D, Kreim N, Carl S . Zc3h13/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15/Spenito to the mA machinery component Wtap/Fl(2)d. Genes Dev. 2018; 32(5-6):415-429. PMC: 5900714. DOI: 10.1101/gad.309146.117. View

Xi Z, Wang P, Xue Y, Shang C, Liu X, Ma J . Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6. Oncotarget. 2017; 8(15):24949-24963. PMC: 5421901. DOI: 10.18632/oncotarget.15327. View

Hou G, Zhao X, Li L, Yang Q, Liu X, Huang C . SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs. Nucleic Acids Res. 2021; 49(5):2859-2877. PMC: 7969013. DOI: 10.1093/nar/gkab065. View

Ueda Y, Ooshio I, Fusamae Y, Kitae K, Kawaguchi M, Jingushi K . AlkB homolog 3-mediated tRNA demethylation promotes protein synthesis in cancer cells. Sci Rep. 2017; 7:42271. PMC: 5304225. DOI: 10.1038/srep42271. View

Geiss-Friedlander R, Melchior F . Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol. 2007; 8(12):947-56. DOI: 10.1038/nrm2293. View

Buchan J, Parker R . Eukaryotic stress granules: the ins and outs of translation. Mol Cell. 2010; 36(6):932-41. PMC: 2813218. DOI: 10.1016/j.molcel.2009.11.020. View

Li A, Chen Y, Ping X, Yang X, Xiao W, Yang Y . Cytoplasmic mA reader YTHDF3 promotes mRNA translation. Cell Res. 2017; 27(3):444-447. PMC: 5339832. DOI: 10.1038/cr.2017.10. View

Nie S, Zhang L, Liu J, Wan Y, Jiang Y, Yang J . ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer. J Exp Clin Cancer Res. 2021; 40(1):284. PMC: 8425158. DOI: 10.1186/s13046-021-02088-1. View

10.

Wang P, Doxtader K, Nam Y . Structural Basis for Cooperative Function of Mettl3 and Mettl14 Methyltransferases. Mol Cell. 2016; 63(2):306-317. PMC: 4958592. DOI: 10.1016/j.molcel.2016.05.041. View

11.

Garcia-Gimenez J, Garces C, Roma-Mateo C, Pallardo F . Oxidative stress-mediated alterations in histone post-translational modifications. Free Radic Biol Med. 2021; 170:6-18. DOI: 10.1016/j.freeradbiomed.2021.02.027. View

12.

Chen J, Zhang Y, Huang C, Shen H, Sun B, Cheng X . mA Regulates Neurogenesis and Neuronal Development by Modulating Histone Methyltransferase Ezh2. Genomics Proteomics Bioinformatics. 2019; 17(2):154-168. PMC: 6620265. DOI: 10.1016/j.gpb.2018.12.007. View

13.

Yang Z, Li J, Feng G, Gao S, Wang Y, Zhang S . MicroRNA-145 Modulates -Methyladenosine Levels by Targeting the 3'-Untranslated mRNA Region of the -Methyladenosine Binding YTH Domain Family 2 Protein. J Biol Chem. 2017; 292(9):3614-3623. PMC: 5339747. DOI: 10.1074/jbc.M116.749689. View

14.

Xu J, Cai Y, Ma Z, Jiang B, Liu W, Cheng J . The RNA helicase DDX5 promotes viral infection via regulating N6-methyladenosine levels on the DHX58 and NFκB transcripts to dampen antiviral innate immunity. PLoS Pathog. 2021; 17(4):e1009530. PMC: 8081163. DOI: 10.1371/journal.ppat.1009530. View

15.

Du C, Lv C, Feng Y, Yu S . Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression. J Exp Clin Cancer Res. 2020; 39(1):223. PMC: 7576758. DOI: 10.1186/s13046-020-01735-3. View

16.

Li M, Zha X, Wang S . The role of N6-methyladenosine mRNA in the tumor microenvironment. Biochim Biophys Acta Rev Cancer. 2021; 1875(2):188522. DOI: 10.1016/j.bbcan.2021.188522. View

17.

Yang S, Wei J, Cui Y, Park G, Shah P, Deng Y . mA mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun. 2019; 10(1):2782. PMC: 6592937. DOI: 10.1038/s41467-019-10669-0. View

18.

Song H, Feng X, Zhang H, Luo Y, Huang J, Lin M . METTL3 and ALKBH5 oppositely regulate mA modification of mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy. 2019; 15(8):1419-1437. PMC: 6613905. DOI: 10.1080/15548627.2019.1586246. View

19.

Cheng L, Zhang X, Huang Y, Zhu Y, Xu L, Li Z . Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p/METTL3/mA/p21 pathway. Oncogenesis. 2021; 10(1):7. PMC: 7801402. DOI: 10.1038/s41389-020-00290-y. View

20.

Anders M, Chelysheva I, Goebel I, Trenkner T, Zhou J, Mao Y . Dynamic mA methylation facilitates mRNA triaging to stress granules. Life Sci Alliance. 2018; 1(4):e201800113. PMC: 6238392. DOI: 10.26508/lsa.201800113. View